D00211 |
Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) |
(P) unclassified |
D00229 |
Amoxicillin (USP); Amoxicillin hydrate (JP18); Amoxicilline (INN); Amoxicillin trihydrate; Amoxil (TN); Dispermox (TN); Pasetocin (TN) |
(P) unclassified |
D00322 |
Fluconazole (JP18/USP/INN); Diflucan (TN) |
(P) unclassified |
D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) unclassified |
D00506 |
Phenobarbital (JP18/USP/INN); Luminal (TN) |
(P) CYP induction: CYP3A |
D00512 |
Phenytoin (JP18/USP/INN); Dilantin (TN) |
(P) CYP induction: CYP3A |
D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) CYP induction: CYP3A |
D00850 |
Minocycline hydrochloride (JP18/USP); Arestin (TN); Dynacin (TN); Minocin (TN); Solodyn (TN) |
(P) unclassified |
D00914 |
Cefuroxime axetil (JP18/USP/INN); Ceftin (TN) |
(P) unclassified |
D00921 |
Ceftazidime (USP); Ceftazidime hydrate (JP18); Ceftazidime pentahydrate; Fortaz (TN); Tazicef (TN) |
(P) unclassified |
D01227 |
Bosentan (USAN); Bosentan hydrate (JAN); Tracleer (TN) |
(P) unclassified |
D01251 |
Ampicillin hydrate (JP18); Ampicillin trihydrate; Amcill (TN) |
(P) unclassified |
D01668 |
Sultamicillin tosilate hydrate (JP18); Sultamicillin tosylate dihydrate; Unasyn (TN) |
(P) unclassified |
D02065 |
Ampicillin sodium and sulbactam sodium (JP18); Unasyn-S (TN) |
(P) unclassified |
D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) |
(P) CYP induction: CYP3A |
D02119 |
Ampicillin sodium (JP18/USP); Omnipen-N (TN); Viccillin (TN) |
(P) unclassified |
D02122 |
Tetracycline hydrochloride (JP18/USP); Bristacycline (TN) |
(P) unclassified |
D02206 |
Buformin hydrochloride (JP18); Dibetos-B (TN) |
(P) unclassified |
D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) Enzyme: CYP3A |
D02502 |
Ampicillin and cloxacillin; Viccillin S (TN) |
(P) unclassified |
D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) unclassified |
D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) CYP induction: CYP3A |
D03230 |
Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN); Humulin (TN) |
(P) unclassified |
D03250 |
Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN); Lantus (TN) |
(P) unclassified |
D04059 |
Mepenzolate bromide and phenobarbital; Trancolon P (TN) |
(P) CYP induction: CYP3A |
D04121 |
Exenatide (JAN/USAN/INN); Byetta (TN) |
(P) unclassified |
D04475 |
Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN); Insulin X 14; NovoRapid (TN); Novolog (TN) |
(P) unclassified |
D04477 |
Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN); Insulin lispro-aabc; Humalog (TN); Lyumjev (TN) |
(P) unclassified |
D04539 |
Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN); Levemir (TN) |
(P) unclassified |
D04540 |
Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN); Apidra (TN) |
(P) unclassified |
D04547 |
Insulin, isophane (USP); Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18); Isophane insulin (aqueous suspension) (JAN); Humalog PEN (TN) |
(P) unclassified |
D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) unclassified |
D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
D06485 |
Amoxicillin hydrate and potassium clavulanate; Augmentin (TN) |
(P) unclassified |
D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) CYP induction: CYP3A |
D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) unclassified |
D08080 |
Insulin injection, biphasic isophane (BAN); Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18); Insulin Humacart (TN) |
(P) unclassified |
D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(P) unclassified |
D09727 |
Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN); Tresiba (TN) |
(P) unclassified |
D09729 |
Lixisenatide (JAN/USAN/INN); Adlyxin (TN); Lyxumia (TN) |
(P) unclassified |
D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) CYP inhibition: CYP3A |
D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) unclassified |
D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
D10519 |
Rabeprazole, amoxicillin and clarithromycin; Rabecure (TN) |
(P) unclassified |
D10520 |
Rabeprazole, amoxicillin and metronidazole; Rabefine (TN) |
(P) unclassified |
D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) Enzyme: CYP3A |
D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) Enzyme: CYP3A / CYP induction: CYP3A |
D10570 |
Insulin degludec (genetical recombination) and insulin aspart (genetical recombination); Ryzodeg (TN) |
(P) unclassified |
D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) Enzyme: CYP3A / CYP inhibition: CYP3A |
D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) CYP inhibition: CYP3A |
D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) unclassified |
D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) unclassified |
D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) CYP inhibition: CYP3A |
D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) CYP inhibition: CYP3A |
D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) Enzyme: CYP3A / CYP induction: CYP3A |
D11034 |
Insulin glargine and lixisenatide; Insulin glargine (genetical recombination) and lixisenatide; Soliqua (TN) |
(P) unclassified |
D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) unclassified |
D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) Enzyme: CYP3A |
D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
D11360 |
Tirzepatide (JAN/USAN); Mounjaro (TN) |
(P) unclassified |
D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
D11567 |
Insulin degludec and liraglutide; Xultophy (TN) |
(P) unclassified |
D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) unclassified |
D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) CYP inhibition: CYP3A |
D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) CYP inhibition: CYP3A |
D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) Enzyme: CYP3A |
D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) Enzyme: CYP3A / CYP inhibition: CYP3A |